AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas

Matthew L. Bush(University of Kentucky), Abraham Jacob(Fairview Health Services)

Neuro-Oncology

July 21, 2011

10.1093/neuonc/nor072

Cited by 80

Related Papers

Clinical Practice Guideline: Ménière’s Disease

|Otolaryngology|2020|301

Clinical Practice Guideline: Ménière’s Disease Executive Summary

|Otolaryngology|2020|85

Older Individuals Meeting Medicare Cochlear Implant Candidacy Criteria in Noise but Not in Quiet: Are These Patients Improved by Surgery?

|Otology & Neurotology|2016|34